Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QNXFY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
cN110974975B C-00
|
|||||
| Synonyms |
C-00
Click to Show/Hide
|
|||||
| Organization |
Chengdu Bailidote Biological Pharmaceutical Co ltd; Sichuan Baili Pharmaceutical Co Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.19
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
CN110974975B-C-00-linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
CN110974975B-C-00-linker-MMAE
|
|||||